ONCO — Onconetix Inc · P/E 0.0, rev $815.4K

Onconetix Inc (ONCO) is a biotechnology company listed on NASDAQ.

Latest reported ONCO revenue for 2025-12-31 was $815.4K. Net income was -$14.0M. Revenue was down 67.7% from 2024-12-31 to 2025-12-31. ONCO currently screens at market cap $3.7M and trailing P/E 0.0.

Use this ONCO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ONCO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ONCO SEC filings page. Lician reads the product cache first so this HTML stays unique to Onconetix Inc even when a live quote feed is slow.

Onconetix Inc latest statements (FY2025)

Latest cached year on this hub. Full ONCO income, balance, and cash tables.

  • Revenue$815.4K
  • Net Income-$14.0M
  • Total Assets$24.9M
  • Total Debt$0
  • Free Cash Flow$0

ONCO recent filings